Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-02-010023
Filing Date
2002-10-29
Accepted
2002-10-29 11:55:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SCHEDULE 13D y64932sc13dza.txt SC 13D/A 21174
3 LOAN FACILITY AGREEMENT y64932exv99w1.txt EX-99.1 62982
4 GUARANTEE y64932exv99w2.txt EX-99.2 5230
  Complete submission text file 0000950123-02-010023.txt   91434
Mailing Address
Business Address ONE EXECUTIVE DR P O BOX 1399 FORT LEE NJ 07024 2019477774
ALPHARMA INC (Subject) CIK: 0000730469 (see all company filings)

EIN.: 222095212 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35893 | Film No.: 02800729
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address HARBITZALLEEN 3 SKOYAN OSLO NORWAY
A L INDUSTRIER AS (Filed by) CIK: 0001034010 (see all company filings)